Nothing is more awesome than seeing our clients grow and succeed.
Congrats to the entire Alumis team on raising $259 million, the largest private round this year. Woohoo!

Alumis will use the funds to advance development of its oral therapies designed to tackle immune dysfunction and help launch a phase 3 psoriasis trial.

Click here to learn more.